Nurix Therapeutics Inc
(NRIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 08-2024 | 05-2024 | 02-2024 | 11-2023 | 08-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 99,044 | 116,790 | 49,813 | 54,627 | 42,304 |
| Marketable Securities | 349,008 | 326,349 | 194,180 | 233,281 | 216,548 |
| Receivables | N/A | N/A | N/A | N/A | 2,000 |
| TOTAL | $456,043 | $450,217 | $250,969 | $295,503 | $267,949 |
| Non-Current Assets | |||||
| PPE Net | 17,069 | 18,557 | 17,871 | 16,808 | 16,581 |
| Investments And Advances | 9,472 | 9,380 | 10,292 | 7,421 | 9,882 |
| Other Non-Current Assets | 31,016 | 32,877 | 33,542 | 35,866 | 13,783 |
| TOTAL | $57,557 | $60,814 | $61,705 | $60,095 | $40,246 |
| Total Assets | $513,600 | $511,031 | $312,674 | $355,598 | $308,195 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,918 | 2,813 | 5,918 | 6,401 | 2,187 |
| Accrued Expenses | 27,828 | 23,263 | 28,318 | 24,970 | 21,907 |
| TOTAL | $86,296 | $80,779 | $87,623 | $86,958 | $61,493 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 47,997 | 46,769 | 46,077 | 48,098 | 32,037 |
| Other Non-Current Liabilities | 20,590 | 20,885 | 21,846 | 23,125 | 2,642 |
| TOTAL | $50,448 | $59,559 | $56,303 | $68,147 | $12,885 |
| Total Liabilities | $136,744 | $140,338 | $143,926 | $155,105 | $74,378 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 70,836 | 64,412 | 49,151 | 48,894 | 48,504 |
| Common Shares | 67 | 64 | 49 | 49 | 49 |
| Retained earnings | -680,220 | -631,264 | -586,718 | -545,200 | -503,244 |
| Other shareholders' equity | 344 | -135 | -350 | -655 | -1,228 |
| TOTAL | $376,856 | $370,693 | $168,748 | $200,493 | $233,817 |
| Total Liabilities And Equity | $513,600 | $511,031 | $312,674 | $355,598 | $308,195 |